At a glance
ClinicalIndex Comparison RecordN/ACompleted· 96,883 enrolled
Drug / intervention
Non applicablebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis - Serology
Institut National de la Santé Et de la Recherche Médicale, France·observational·Posted May 18, 2020·Updated Dec 10, 2025
In Brief
An observational study evaluating Non applicable for SARS-CoV 2. Completed, enrolled 96,883 participants across 1 site.
Detailed Summary
This study aims to quantify and follow the cumulative incidence of SARS-CoV-2 infection in the French population using serological tests and to assess the determinants of infection from Constances, E3N-E4N, ELFE-Epipage 2 and NutriNet-Santé cohorts.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSARS-CoV 2
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartMay 2020
First PostedMay 2020
Primary CompletionDec 2022
Study CompletionApr 2023
TodayJul 2026
First PostedMay 18, 2020
Enrollment StartMay 1, 2020
Primary CompletionDec 31, 2022
Study CompletionApr 11, 2023
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 6.1 years ago
Interventions
Non applicablebiological
to collect data from questionnaires and to collect serological samples